Screver AG

Screver is an AI-native launch intelligence platform for global pharmaceutical companies. It addresses a core industry challenge: launches underperform not because of product quality, but due to late decisions, fragmented data, and missing real-world signals across markets.

Screver AI leverages agentic AI, real-time stakeholder insights, and advanced analytics to orchestrate launch decisions across regions, channels, and lifecycle phases. Its flagship module, Product Launch IQ, continuously monitors HCP, patient, and execution signals to detect risks early, optimize engagement, and accelerate adoption.

With proven enterprise traction and recurring revenue, Screver is scaling internationally, with the U.S. as a core strategic market.